- Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
Kira V. Blankenbach et al, 2016, Front. Pharmacol. CrossRef - Regulation of adipogenesis by ceramide 1-phosphate
Marta Ordoñez et al, 2018, Experimental Cell Research CrossRef - Obesity and dyslipidemia
Jelena Vekic et al, 2018, Metabolism CrossRef - Ceramide and sphingosine 1-phosphate in adipose dysfunction
Zijian Fang et al, 2019, Progress in Lipid Research CrossRef - Ceramide and sphingosine 1-phosphate in adipose dysfunction
Zijian Fang et al, 2019, Progress in Lipid Research CrossRef - The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells – new opportunities in regenerative medicine
Krzysztof Marycz et al, 2015 CrossRef - A review on possible therapeutic targets to contain obesity: The role of phytochemicals
Meriga Balaji et al, 2016, Obesity Research & Clinical Practice CrossRef - Implication of phosphatidylethanolamine N-methyltransferase in adipocyte differentiation
Natalia Presa et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef - Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes
Xiyuan Wu et al, 2020, IJMS CrossRef - Novel insights into the pathological mechanisms of metabolic related dyslipidemia
Xin Su et al, 2021, Mol Biol Rep CrossRef - Adipose Tissue Immunometabolism and Apoptotic Cell Clearance
Tamás Röszer, 2021, Cells CrossRef - S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
Sagarika Chakrabarty et al, 2022, Adipocyte CrossRef